Alyami NM. MicroRNAs Role in Breast Cancer: Theranostic Application in Saudi Arabia. Front Oncol. 2021;11:717759.

https://doi.org/10.3389/fonc.2021.717759

PMid:34760689 PMCid:PMC8573223

Shiovitz S, Korde LA. Genetics of breast cancer: A topic in evolution. Ann Oncol. 2015;26(7):1291-9.

https://doi.org/10.1093/annonc/mdv022

PMid:25605744 PMCid:PMC4478970

Moo TA, Sanford R, Dang C, Morrow M. Overview of Breast Cancer Therapy. PET Clin. 2018;13(3):339-54.

https://doi.org/10.1016/j.cpet.2018.02.006

PMid:30100074 PMCid:PMC6092031

Hua H, Zhang H, Kong Q, Jiang Y. Mechanisms for estrogen receptor expression in human cancer. Exp Hematol Oncol. 2018;7:24.

https://doi.org/10.1186/s40164-018-0116-7

PMid:30250760 PMCid:PMC6148803

Cizeron-Clairac G, Lallemand F, Vacher S, Lidereau R, Bieche I, Callens C. MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers? BMC Cancer. 2015;15(1):499.

https://doi.org/10.1186/s12885-015-1505-5

PMid:26141719 PMCid:PMC4491222

Macfarlane LA, Murphy PR. MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics. 2010;11(7):537-61.

https://doi.org/10.2174/138920210793175895

PMid:21532838 PMCid:PMC3048316

Wahid F, Shehzad A, Khan T, Kim YY. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta. 2010;1803(11):1231-43.

https://doi.org/10.1016/j.bbamcr.2010.06.013

PMid:20619301

Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012;6(6):590-610.

https://doi.org/10.1016/j.molonc.2012.09.006

PMid:23102669 PMCid:PMC5528350

Khordadmehr M, Shahbazi R, Ezzati H, Jigari-Asl F, Sadreddini S, Baradaran B. Key microRNAs in the biology of breast cancer; emerging evidence in the last decade. J Cell Physiol. 2019;234(6):8316-26.

https://doi.org/10.1002/jcp.27716

PMid:30422324

Dalmay T, Edwards DR. MicroRNAs and the hallmarks of cancer. Oncogene. 2006;25(46):6170-5.

https://doi.org/10.1038/sj.onc.1209911

PMid:17028596

Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer. 2006;94(6):776-80.

https://doi.org/10.1038/sj.bjc.6603023

PMid:16495913 PMCid:PMC2361377

Van Der Auwera I, Limame R, Van Dam P, Vermeulen PB, Dirix LY, Van Laere SJ. Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. Br J Cancer. 2010;103:532-41.

https://doi.org/10.1038/sj.bjc.6605787

PMid:20664596 PMCid:PMC2939785

Lan H, Lu H, Wang X, Jin H. MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed Res Int. 2015;2015:125094.

https://doi.org/10.1155/2015/125094

PMid:25874201 PMCid:PMC4385606

Jang JY, Kim YS, Kang KN, Kim KH, Park YJ, Kim CW. Multiple microRNAs as biomarkers for early breast cancer diagnosis. Mol Clin Oncol. 2021;14(2):31.

https://doi.org/10.3892/mco.2020.2193

PMid:33414912 PMCid:PMC7783718

Loh HY, Norman BP, Lai KS, Rahman NMANA, Alitheen NBM, Osman MA. The Regulatory Role of MicroRNAs in Breast Cancer. Int J Mol Sci. 2019;20(19):4940.

https://doi.org/10.3390/ijms20194940

PMid:31590453 PMCid:PMC6801796

Denkiewicz M, Saha I, Rakshit S, Sarkar JP, Plewczynski D. Identification of Breast Cancer Subtype Specific MicroRNAs Using Survival Analysis to Find Their Role in Transcriptomic Regulation. Front Genet. 2019;10:1047.

https://doi.org/10.3389/fgene.2019.01047

PMid:31798622 PMCid:PMC6837165

Men L, Nie D, Nie H. MicroRNA-577 inhibits cell proliferation and invasion in non-small cell lung cancer by directly targeting homeobox A1. Mol Med Rep. 2019;19(3):1875-82.

https://doi.org/10.3892/mmr.2019.9804

PMid:30628697

Luo Y, Wu J, Wu Q, Li X, Wu J, Zhang J, et al. miR-577 Regulates TGF-β Induced Cancer Progression through a SDPR-Modulated Positive-Feedback Loop with ERK-NF-κB in Gastric Cancer. Mol Ther. 2019;27(6):1166-82.

https://doi.org/10.1016/j.ymthe.2019.02.002

PMid:30879950 PMCid:PMC6554531

Jiang H, Ju H, Zhang L, Lu H, Jie K. microRNA-577 suppresses tumor growth and enhances chemosensitivity in colorectal cancer. J Biochem Mol Toxicol. 2017;31(6):e21888.

https://doi.org/10.1002/jbt.21888

PMid:28150434

Wang LY, Li B, Jiang HH, Zhuang LW, Liu Y. Inhibition effect of miR-577 on hepatocellular carcinoma cell growth via targeting β-catenin. Asian Pac J Trop Med. 2015;8(11):923-9.

https://doi.org/10.1016/j.apjtm.2015.10.001

PMid:26614992

Zhang XT, Dong SH, Zhang JY, Shan B. MicroRNA-577 promotes the sensitivity of chronic myeloid leukemia cells to imatinib by targeting NUP160. Eur Rev Med Pharmacol Sci. 2019;23(16):7008-15.

Tang H, Lv W, Sun W, Bi Q, Hao Y. MiR-505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT-NFκB pathway in NSCLC cells. Int J Mol Med. 2019;43(3):1203-16.

https://doi.org/10.3892/ijmm.2018.4041

Kapora E, Feng S, Liu W, Sakhautdinova I, Gao B, Tan W. MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer. Biosci Rep. 2019;39(7):20191221.

https://doi.org/10.1042/BSR20191221

PMid:31266812 PMCid:PMC6658724

Tang Y, Wu B, Huang S, Peng X, Li X, Huang X, et al. Downregulation of miR-505-3p predicts poor bone metastasis-free survival in prostate cancer. Oncol Rep. 2019;41(1):57-66.

https://doi.org/10.3892/or.2018.6826

Tian L, Wang Z, Hao J, Zhang X. miR‐505 acts as a tumor suppressor in gastric cancer progression through targeting HMGB1. J Cell Biochem. 2019;120(5):8044-52.

https://doi.org/10.1002/jcb.28082

PMid:30525214

Ren L, Yao Y, Wang Y, Wang S. MiR-505 suppressed the growth of hepatocellular carcinoma cells via targeting IGF-1R. Biosci Rep. 2019;39(7):20182442.

https://doi.org/10.1042/BSR20182442

PMid:31160483 PMCid:PMC6603277

Rong Z, Rong Y, Li Y, Zhang L, Peng J, Zou B, et al. Development of a Novel Six-miRNA-Based Model to Predict Overall Survival Among Colon Adenocarcinoma Patients. Front Oncol. 2020;10:26.

https://doi.org/10.3389/fonc.2020.00026

PMid:32154160 PMCid:PMC7047168

Yao B, Niu Y, Li Y, Chen T, Wei X, Liu Q. High-matrix-stiffness induces promotion of hepatocellular carcinoma proliferation and suppression of apoptosis via miR-3682-3p-PHLDA1-FAS pathway. J Cancer. 2020;11(21):6188-203.

https://doi.org/10.7150/jca.45998

PMid:33033502 PMCid:PMC7532500

Li S, Hang L, Ma Y, Wu C. Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients. J Cell Mol Med. 2016;20(12):2259-68.

https://doi.org/10.1111/jcmm.12906

PMid:27489139 PMCid:PMC5134390

Rong H, Liu D. Identification of differentially expressed miRNAs associated with thermal injury in epidermal stem cells based on RNA sequencing. Exp Ther Med. 2020;19(3):2218-28.

https://doi.org/10.3892/etm.2020.8448

PMid:32104287 PMCid:PMC7027234

Cho HJ, Baek GO, Seo CW, Ahn HR, Sung S, Son JA, et al. Exosomal microRNA‐4661‐5p-based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinoma. Cancer Med. 2020;9(15):5459-72.

https://doi.org/10.1002/cam4.3230

PMid:32537885 PMCid:PMC7402848

Li X, An Z, Li P, Liu H. A prognostic model for lung adenocarcinoma patient survival with a focus on four miRNAs. Oncol Lett. 2017;14(3):299-5.

https://doi.org/10.3892/ol.2017.6481

PMid:28927049 PMCid:PMC5588086